{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:42:20Z","timestamp":1792608140855,"version":"4.5.0"},"reference-count":225,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005294","name":"Massachusetts General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005294","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1053\/j.semdp.2019.03.002","type":"journal-article","created":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T12:27:53Z","timestamp":1552912073000},"page":"229-239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Paraneoplastic syndromes and other systemic disorders associated with neuroendocrine neoplasms"],"prefix":"10.1053","volume":"36","author":[{"given":"Julie","family":"Guilmette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e2nia","family":"Nos\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1053\/j.semdp.2019.03.002_bib0001","doi-asserted-by":"crossref","first-page":"838","DOI":"10.4065\/mcp.2010.0099","article-title":"Paraneoplastic syndromes: an approach to diagnosis and treatment","volume":"85","author":"Pelosof","year":"2010","journal-title":"Mayo Clin Proc"},{"issue":"11","key":"10.1053\/j.semdp.2019.03.002_bib0002","first-page":"1076","article-title":"Mucocutaneous paraneoplastic syndromes associated with hematologic malignancies","volume":"25","author":"Steele","year":"2011","journal-title":"Oncology"},{"issue":"1","key":"10.1053\/j.semdp.2019.03.002_bib0003","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.critrevonc.2005.04.004","article-title":"Metabolic emergencies","volume":"58","author":"Spinazze","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"10.1053\/j.semdp.2019.03.002_bib0004","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJMcp042806","article-title":"Hypercalcemia associated with Cancer","volume":"352","author":"Stewart","year":"2005","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1053\/j.semdp.2019.03.002_bib0005","first-page":"244","article-title":"Cancer-related hypercalcemia","volume":"56","author":"Seccareccia","year":"2010","journal-title":"Can Fam Physician"},{"issue":"10","key":"10.1053\/j.semdp.2019.03.002_bib0006","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.2215\/CJN.02470312","article-title":"Onco-nephrology: the pathophysiology and treatment of malignancy-associated hypercalcemia","volume":"7","author":"Rosner","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.semdp.2019.03.002_bib0007","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1210\/jc.2014-4250","article-title":"PTHrP-mediated hypercalcemia: causes and survival in 138 patients","volume":"100","author":"Donovan","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1053\/j.semdp.2019.03.002_bib0008","doi-asserted-by":"crossref","first-page":"R173","DOI":"10.1530\/ERC-17-0036","article-title":"Paraneoplastic endocrine syndromes","volume":"24","author":"Dimitriadis","year":"2017","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"10.1053\/j.semdp.2019.03.002_bib0009","first-page":"1365","article-title":"Intractable hypercalcaemia due to parathyroid hormone-related peptide secretion by a carcinoid tumour","volume":"10","author":"Mantzoros","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"926","key":"10.1053\/j.semdp.2019.03.002_bib0010","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/pmj.78.926.752","article-title":"Presentation of a PTHrP-secreting pancreatic neuroendocrine tumour, with hypercalcaemic crisis, pre-eclampsia, and renal failure","volume":"78","author":"Abraham","year":"2002","journal-title":"Postgrad Med J"},{"issue":"6","key":"10.1053\/j.semdp.2019.03.002_bib0011","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1445-5994.2009.01934.x","article-title":"Hypercalcaemia caused by a carcinoid tumour","volume":"39","author":"Brzozowska","year":"2009","journal-title":"Intern Med J"},{"issue":"16","key":"10.1053\/j.semdp.2019.03.002_bib0012","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006201","article-title":"Pancreatic carcinoids (serotonin-producing pancreatic neuroendocrine neoplasms): report of 5 cases and review of the literature","volume":"96","author":"Tsoukalas","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1053\/j.semdp.2019.03.002_bib0013","first-page":"313","article-title":"Endocrine paraneoplastic syndromes in lung cancer","volume":"9","author":"Efthymiou","year":"2018","journal-title":"Hormones"},{"issue":"2","key":"10.1053\/j.semdp.2019.03.002_bib0014","first-page":"125","article-title":"Hypercalcemia of malignancy: an update on pathogenesis and management","volume":"12","author":"Mirrakhimov","year":"2015","journal-title":"N Am J Med Sci"},{"issue":"4","key":"10.1053\/j.semdp.2019.03.002_bib0015","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.bone.2006.11.009","article-title":"PTHrP, calcitonin and calcitriol in a case of severe, protracted and refractory hypercalcemia due to a pancreatic neuroendocrine tumor","volume":"40","author":"Van den Eynden","year":"2007","journal-title":"Bone"},{"issue":"1","key":"10.1053\/j.semdp.2019.03.002_bib0016","first-page":"260","article-title":"Parathyroid hormone, parathyroid hormone-related protein, and calcitonin","volume":"265","author":"Wysolmerski","year":"2017","journal-title":"Vitamin"},{"issue":"4","key":"10.1053\/j.semdp.2019.03.002_bib0017","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1023\/A:1026578720736","article-title":"Parathyroid hormone and parathyroid hormone-related protein","volume":"1","author":"Nissenson","year":"2013","journal-title":"Rev Endocr Metab Disord"},{"issue":"1","key":"10.1053\/j.semdp.2019.03.002_bib0018","first-page":"1","article-title":"Malignancy-related hypercalcemia: pathophysiology and diagnosis","volume":"11","author":"Lumachi","year":"2014","journal-title":"Anticancer Res"},{"issue":"10","key":"10.1053\/j.semdp.2019.03.002_bib0019","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1158\/1541-7786.MCR-09-0131","article-title":"Reconstitution of amphiregulin-epidermal growth factor receptor signaling in lung squamous cell carcinomas activates PTHrP gene expression and contributes to cancer\u2013mediated diseases of the bone","volume":"7","author":"Gilmore","year":"2009","journal-title":"Mol Cancer Res"},{"issue":"3","key":"10.1053\/j.semdp.2019.03.002_bib0020","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1158\/0008-5472.CAN-10-2993","article-title":"TGF-\u03b2 promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling","volume":"71","author":"Johnson","year":"2011","journal-title":"Cancer Res"},{"issue":"4","key":"10.1053\/j.semdp.2019.03.002_bib0021","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1053\/j.tcam.2012.09.003","article-title":"Paraneoplastic hypercalcemia","volume":"27","author":"Bergman","year":"2012","journal-title":"Top Companion Anim Med"},{"issue":"2","key":"10.1053\/j.semdp.2019.03.002_bib0022","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1210\/jc.2005-2095","article-title":"Hypercalcemia of malignancy due to ectopic transactivation of the parathyroid hormone gene","volume":"91","author":"VanHouten","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1053\/j.semdp.2019.03.002_bib0023","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/qjmed\/hcu166","article-title":"Use of denosumab in parathyroid carcinoma with refractory hypercalcemia","volume":"108","author":"Tong C","year":"2015","journal-title":"QJM"},{"issue":"2","key":"10.1053\/j.semdp.2019.03.002_bib0024","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3892\/etm.2011.205","article-title":"Prevalence of serum D deficiency and insufficiency in cancer","volume":"2","author":"Gupta","year":"2010","journal-title":"Exp Ther Med"},{"issue":"1","key":"10.1053\/j.semdp.2019.03.002_bib0025","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1053\/j.ajkd.2013.06.025","article-title":"Approach to diagnosis and treatment of hypercalcemia in a patient with malignancy","volume":"63","author":"Reagan","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.semdp.2019.03.002_bib0026","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1634\/theoncologist.2011-0400","article-title":"Diagnosis and management of hyponatremia in cancer patients","volume":"17","author":"Castillo","year":"2012","journal-title":"Oncologist"},{"issue":"8","key":"10.1053\/j.semdp.2019.03.002_bib0027","first-page":"105","article-title":"Role of tolvaptan in the management of hyponatremia in patients with lung and other cancers: current data and future perspectives","volume":"22","author":"Thajudeen","year":"2016","journal-title":"Cancer Manag Res"},{"issue":"1","key":"10.1053\/j.semdp.2019.03.002_bib0028","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.lungcan.2007.03.003","article-title":"Syndrome of inappropriate antidiuretic hormone secretion and ectopic ACTH production in small cell lung carcinoma","volume":"57","author":"M\u00fcssig","year":"2007","journal-title":"Lung Cancer"},{"issue":"961","key":"10.1053\/j.semdp.2019.03.002_bib0029","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1136\/pgmj.2005.036889","article-title":"Is the paraneoplastic syndrome of inappropriate antidiuretic hormone secretion in lung cancer always attributable to the small cell variety?","volume":"81","author":"Tho","year":"2005","journal-title":"Postgrad Med J"},{"issue":"9-10","key":"10.1053\/j.semdp.2019.03.002_bib0030","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.3109\/0284186X.2016.1170198","article-title":"Malignancy associated SIADH: characterization and clinical implications","volume":"55","author":"Goldvaser","year":"2016","journal-title":"Acta Oncol (Madr)"},{"issue":"6","key":"10.1053\/j.semdp.2019.03.002_bib0031","first-page":"40","article-title":"Paraneoplastic syndromes: an approach to diagnosis and treatment","volume":"33","author":"Pelosof","year":"2015","journal-title":"Mayo Clin Proc"},{"issue":"Suppl 1","key":"10.1053\/j.semdp.2019.03.002_bib0032","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1530\/EJE-09-1063","article-title":"The syndrome of inappropriate antidiuretic hormone: prevalence, causes and consequences","volume":"162","author":"Hannon","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1053\/j.semdp.2019.03.002_bib0033","doi-asserted-by":"crossref","first-page":"490","DOI":"10.6061\/clinics\/2018\/e490s","article-title":"Carcinoid syndrome: update on the pathophysiology and treatment","volume":"73","author":"Ferrari","year":"2018","journal-title":"Clinics"},{"issue":"5","key":"10.1053\/j.semdp.2019.03.002_bib0034","first-page":"662","article-title":"Complications from carcinoid syndrome: review of the current evidence","volume":"8","author":"Mota","year":"2016","journal-title":"Ecancermedicalscience"},{"issue":"1","key":"10.1053\/j.semdp.2019.03.002_bib0035","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1470-2045(07)70410-2","article-title":"Gastroenteropancreatic neuroendocrine tumours","volume":"9","author":"Modlin","year":"2008","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1053\/j.semdp.2019.03.002_bib0036","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/cncr.11105","article-title":"A 5-decade analysis of 13,715 carcinoid tumors","volume":"97","author":"Modlin","year":"2003","journal-title":"Cancer"},{"issue":"6","key":"10.1053\/j.semdp.2019.03.002_bib0037","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2005.03.038","article-title":"Current status of gastrointestinal carcinoids","volume":"128","author":"Modlin","year":"2005","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1053\/j.semdp.2019.03.002_bib0038","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jtho.2016.11.2222","article-title":"Neuroendocrine tumors of the lung: current challenges and advances in the diagnosis and management of well-differentiated disease","volume":"12","author":"Hendifar","year":"2017","journal-title":"J Thorac Oncol"},{"issue":"7","key":"10.1053\/j.semdp.2019.03.002_bib0039","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/0959-8049(96)00049-4","article-title":"Carcinoid of the pancreas: clinical characteristics and morphological features","volume":"32","author":"Maurer","year":"1996","journal-title":"Eur J Cancer Part A"},{"issue":"6","key":"10.1053\/j.semdp.2019.03.002_bib0040","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/MPA.0b013e31822041a9","article-title":"Serotonin-producing enterochromaffin cell tumors of the pancreas: clinicopathologic study of 15 cases and comparison with intestinal enterochromaffin cell tumors","volume":"40","author":"La Rosa","year":"2011","journal-title":"Pancreas"},{"issue":"4","key":"10.1053\/j.semdp.2019.03.002_bib0041","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000381930","article-title":"Carcinoid heart disease: from pathophysiology to treatment \u2013 \u201cSomething in the Way It Moves","volume":"101","author":"Grozinsky-Glasberg","year":"2015","journal-title":"Neuroendocrinology"},{"issue":"24","key":"10.1053\/j.semdp.2019.03.002_bib0042","first-page":"4770","article-title":"Neuroendocrine tumors and fibrosis: an unsolved mystery?","volume":"123","author":"Laskaratos","year":"2017","journal-title":"Am Cancer Soc"},{"issue":"19","key":"10.1053\/j.semdp.2019.03.002_bib0043","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1136\/heartjnl-2017-311261","article-title":"Carcinoid heart disease","volume":"103","author":"Hassan","year":"2017","journal-title":"Heart"},{"issue":"3","key":"10.1053\/j.semdp.2019.03.002_bib0044","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ecl.2018.04.012","article-title":"Carcinoid heart disease: a review","volume":"47","author":"Hayes","year":"2018","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"10","key":"10.1053\/j.semdp.2019.03.002_bib0045","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jacc.2016.12.030","article-title":"Diagnosing and managing carcinoid heart disease in patients with neuroendocrine tumors: an expert statement","volume":"69","author":"Davar","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1053\/j.semdp.2019.03.002_bib0046","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/qjmed\/hcp191","article-title":"Intra-abdominal fibrosis in a recent cohort of patients with neuroendocrine ('carcinoid\u2019) tumours of the small bowel","volume":"103","author":"Druce","year":"2010","journal-title":"QJM"},{"issue":"1","key":"10.1053\/j.semdp.2019.03.002_bib0047","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/bjs.10333","article-title":"Clinical signs of fibrosis in small intestinal neuroendocrine tumours","volume":"104","author":"Daskalakis","year":"2017","journal-title":"Br J Surg"},{"issue":"5","key":"10.1053\/j.semdp.2019.03.002_bib0048","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrendo.2009.51","article-title":"Fibrosis and carcinoid syndrome: from causation to future therapy","volume":"5","author":"Druce","year":"2009","journal-title":"Nat Rev Endocrinol"},{"issue":"13","key":"10.1053\/j.semdp.2019.03.002_bib0049","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1001\/jama.1971.03190130066019","article-title":"Retroperitoneal fibrosis, regional enteritis, and carcinoid tumors","volume":"217","author":"Taylor","year":"1971","journal-title":"JAMA J Am Med Assoc"},{"issue":"1","key":"10.1053\/j.semdp.2019.03.002_bib0050","first-page":"14","article-title":"Scleroderma overlap syndrome","volume":"13","author":"Balbir-Gurman","year":"2011","journal-title":"Isr Med Assoc J"},{"issue":"1","key":"10.1053\/j.semdp.2019.03.002_bib0051","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2133.2004.06273.x","article-title":"Cutaneous manifestations of the malignant carcinoid syndrome","volume":"152","author":"Bell","year":"2005","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1053\/j.semdp.2019.03.002_bib0052","first-page":"49","article-title":"Pleural involvement in the carcinoid syndrome","volume":"86","author":"Moss","year":"1993","journal-title":"QJM"},{"issue":"12","key":"10.1053\/j.semdp.2019.03.002_bib0053","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1111\/j.1572-0241.2004.40507.x","article-title":"Carcinoid tumors and fibrosis: an association with no explanation","volume":"99","author":"Modlin","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1053\/j.semdp.2019.03.002_bib0054","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/thx.46.11.857","article-title":"Synchronous double primary lung cancers of squamous and neuroendocrine type associated with cryptogenic fibrosing alveolitis","volume":"46","author":"Seo","year":"1991","journal-title":"Thorax"},{"issue":"2","key":"10.1053\/j.semdp.2019.03.002_bib0055","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000443167","article-title":"ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site","volume":"103","author":"Pavel","year":"2016","journal-title":"Neuroendocrinology"},{"issue":"7","key":"10.1053\/j.semdp.2019.03.002_bib0056","doi-asserted-by":"crossref","first-page":"R261","DOI":"10.1530\/ERC-16-0538","article-title":"Effect of hormone secretory syndromes on neuroendocrine tumor prognosis","volume":"24","author":"Zandee","year":"2017","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"10.1053\/j.semdp.2019.03.002_bib0057","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/0974-7753.66910","article-title":"Endocrinology of hirsutism","volume":"2","author":"Kopera","year":"2010","journal-title":"Int J Trichology"},{"issue":"4","key":"10.1053\/j.semdp.2019.03.002_bib0058","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1529-8019.2006.00077.x","article-title":"Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome","volume":"19","author":"Lowenstein","year":"2006","journal-title":"Dermatol Ther"},{"issue":"4","key":"10.1053\/j.semdp.2019.03.002_bib0059","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1148\/rg.304095745","article-title":"Clinical syndromes associated with ovarian neoplasms: a comprehensive review","volume":"30","author":"Shanbhogue","year":"2010","journal-title":"RadioGraphics"},{"issue":"1","key":"10.1053\/j.semdp.2019.03.002_bib0060","doi-asserted-by":"crossref","first-page":"56","DOI":"10.6118\/jmm.2015.21.1.56","article-title":"Postmenopausal Meigs\u2019 syndrome in elevated CA-125: a case report","volume":"21","author":"Park","year":"2015","journal-title":"J Menopausal Med"},{"issue":"6","key":"10.1053\/j.semdp.2019.03.002_bib0061","first-page":"327","article-title":"Androgen secreting ovarian tumors","volume":"5","author":"Brojeni","year":"2017","journal-title":"MOJ Women's Heal"},{"key":"10.1053\/j.semdp.2019.03.002_bib0062","article-title":"Peripheral and ovarian venous concentrations of various steroid hormones in virilizing ovarian tumors","author":"Meldrum","year":"1979","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1053\/j.semdp.2019.03.002_bib0063","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3109\/09513599909167586","article-title":"Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study","volume":"13","author":"Waggoner","year":"1999","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"10.1053\/j.semdp.2019.03.002_bib0064","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1210\/jc.2007-2437","article-title":"Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline","volume":"93","author":"Martin","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1053\/j.semdp.2019.03.002_bib0065","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1210\/jc.2018-00241","article-title":"Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline","volume":"103","author":"Martin","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1053\/j.semdp.2019.03.002_bib0066","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s00292-003-0622-0","article-title":"Endocrine-active tumors of the ovary","volume":"24","author":"Stegner","year":"2003","journal-title":"Pathologe"},{"issue":"11","key":"10.1053\/j.semdp.2019.03.002_bib0067","doi-asserted-by":"crossref","first-page":"765","DOI":"10.6061\/clinics\/2015(11)09","article-title":"Treatment of infertility in women with polycystic ovary syndrome: approach to clinical practice","volume":"70","author":"Melo","year":"2015","journal-title":"Clinics"},{"issue":"2","key":"10.1053\/j.semdp.2019.03.002_bib0068","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/humupd\/dmr042","article-title":"Epidemiology, diagnosis and management of hirsutism: a consensus statement by the androgen excess and polycystic ovary syndrome society","volume":"18","author":"Escobar-Morreale","year":"2012","journal-title":"Hum Reprod Update"},{"issue":"6","key":"10.1053\/j.semdp.2019.03.002_bib0069","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CLEP.S37559","article-title":"Epidemiology, diagnosis, and management of polycystic ovary syndrome","volume":"18","author":"Sirmans","year":"2013","journal-title":"Clin Epidemiol"},{"issue":"12","key":"10.1053\/j.semdp.2019.03.002_bib0070","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1053\/j.semdp.2019.03.002_bib0071","first-page":"995","article-title":"The evaluation and management of hirsutism","volume":"101","author":"Azziz","year":"2003","journal-title":"Obstet Gynecol"},{"issue":"235","key":"10.1053\/j.semdp.2019.03.002_bib0072","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/adc.44.235.291","article-title":"Variations in pattern of pubertal changes in girls","volume":"44","author":"Marshall","year":"1969","journal-title":"Arch Dis Child"},{"issue":"239","key":"10.1053\/j.semdp.2019.03.002_bib0073","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/adc.45.239.13","article-title":"Variations in the pattern of pubertal changes in boys","volume":"45","author":"Marshall","year":"1970","journal-title":"Arch Dis Child"},{"issue":"4","key":"10.1053\/j.semdp.2019.03.002_bib0074","first-page":"936","article-title":"Reexamination of the age limit for defining when puberty is precocious in girls in the United States: implication for evaluation and treatment","volume":"104","author":"Kaplowitz","year":"1999","journal-title":"Int J Confl Manag"},{"issue":"2","key":"10.1053\/j.semdp.2019.03.002_bib0075","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/humupd\/dmh012","article-title":"Precocious puberty and statural growth","volume":"10","author":"Carel","year":"2004","journal-title":"Hum Reprod Update"},{"issue":"3","key":"10.1053\/j.semdp.2019.03.002_bib0076","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s40746-016-0061-9","article-title":"Puberty-defining normal and understanding abnormal","volume":"2","author":"De Silva","year":"2016","journal-title":"Curr Treat Options Pediatr"},{"issue":"6","key":"10.1053\/j.semdp.2019.03.002_bib0077","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1542\/peds.2005-0012","article-title":"Prevalence and incidence of precocious pubertal development in Denmark: an epidemiologic study based on national registries","volume":"116","author":"Teilmann","year":"2005","journal-title":"Pediatrics"},{"issue":"1","key":"10.1053\/j.semdp.2019.03.002_bib0078","first-page":"1","article-title":"Gonadotropin-dependent precocious puberty: neoplastic causes and endocrine considerations","volume":"2010","author":"Stephen","year":"2011","journal-title":"Int J Pediatr Endocrinol"},{"issue":"3","key":"10.1053\/j.semdp.2019.03.002_bib0079","first-page":"771","article-title":"Precocious puberty: a clinical review","volume":"7","author":"Pallavee","year":"2018","journal-title":"Int J Reprod Obstet Gynecol"},{"issue":"10","key":"10.1053\/j.semdp.2019.03.002_bib0080","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3345\/kjp.2012.55.10.388","article-title":"LIN28B polymorphisms are associated with central precocious puberty and early puberty in girls","volume":"55","author":"Park","year":"2012","journal-title":"Korean J Pediatr"},{"issue":"1","key":"10.1053\/j.semdp.2019.03.002_bib0081","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/1756-0500-4-363","article-title":"LIN28B, LIN28A, KISS1, and KISS1R in idiopathic central precocious puberty","volume":"4","author":"Tommiska","year":"2011","journal-title":"BMC Res Notes"},{"issue":"3","key":"10.1053\/j.semdp.2019.03.002_bib0082","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000342212","article-title":"Absence of functional LIN28B mutations in a large cohort of patients with idiopathic central precocious puberty","volume":"78","author":"Silveira-Neto","year":"2012","journal-title":"Horm Res p\u00e6diatrics"},{"issue":"6","key":"10.1053\/j.semdp.2019.03.002_bib0083","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/ng.382","article-title":"Genetic variation in LIN28B is associated with the timing of puberty","volume":"41","author":"Ong","year":"2009","journal-title":"Nat Genet"},{"issue":"6","key":"10.1053\/j.semdp.2019.03.002_bib0084","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1210\/jc.2009-2344","article-title":"LIN28B in constitutional delay of growth and puberty","volume":"95","author":"Tommiska","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"4 Pt 1","key":"10.1053\/j.semdp.2019.03.002_bib0085","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/pr.2011.69","article-title":"Study of leptin levels and gene polymorphisms in patients with central precocious puberty","volume":"71","author":"Su","year":"2012","journal-title":"Pediatr Res"},{"issue":"3","key":"10.1053\/j.semdp.2019.03.002_bib0086","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/humupd\/7.3.292","article-title":"Pathogenesis and epidemiology of precocious puberty. effects of exogenous oestrogens","volume":"7","author":"Partsch","year":"2001","journal-title":"Hum Reprod Update"},{"issue":"1","key":"10.1053\/j.semdp.2019.03.002_bib0087","first-page":"123","article-title":"Precocious puberty following head injury. Case report","volume":"73","author":"Maxwell","year":"1990","journal-title":"JNeurosurg"},{"issue":"8","key":"10.1053\/j.semdp.2019.03.002_bib0088","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1358\/dof.2006.031.08.1009736","article-title":"Peripheral precocious puberty","volume":"31","author":"Davies","year":"2006","journal-title":"Drugs Future"},{"issue":"4","key":"10.1053\/j.semdp.2019.03.002_bib0089","first-page":"e1","article-title":"Peripheral precocious puberty: clinical, diagnostic and therapeutical principles","volume":"76","author":"Soriano Guill\u00e9n","year":"2012","journal-title":"An Pediatr (Barc)"},{"issue":"6","key":"10.1053\/j.semdp.2019.03.002_bib0090","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1515\/JPEM.2007.20.6.653","article-title":"An update on the treatment of precocious puberty in McCune-Albright syndrome and testotoxicosis","volume":"20","author":"Haddad","year":"2007","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"1","key":"10.1053\/j.semdp.2019.03.002_bib0091","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1210\/jcem.87.1.8162","article-title":"Sertoli-Leydig cell tumor of the ovary, a rare cause of precocious puberty in a 12-month-old infant","volume":"87","author":"Choong","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1053\/j.semdp.2019.03.002_bib0092","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jpag.2010.01.003","article-title":"Juvenile granulosa and theca cell tumor of the ovary as a rare cause of precocious puberty: case report and review of literature","volume":"23","author":"Fleming","year":"2010","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"7-8","key":"10.1053\/j.semdp.2019.03.002_bib0093","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2298\/SARH0608305M","article-title":"Ovarian cysts and tumors as the cause of isosexual pseudoprecocious puberty","volume":"134","author":"Mitrovic","year":"2006","journal-title":"Srp Arh Celok Lek"},{"issue":"3","key":"10.1053\/j.semdp.2019.03.002_bib0094","first-page":"367","article-title":"Central precocious puberty: from physiopathological mechanisms to treatment","volume":"28","author":"Chirico","year":"2014","journal-title":"J Biol Regul Homeost Agents"},{"issue":"4","key":"10.1053\/j.semdp.2019.03.002_bib0095","doi-asserted-by":"crossref","first-page":"196","DOI":"10.6065\/apem.2013.18.4.196","article-title":"Basal luteinizing hormone and follicular stimulating hormone: is it sufficient for the diagnosis of precocious puberty in girls?","volume":"18","author":"Lee","year":"2013","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"2","key":"10.1053\/j.semdp.2019.03.002_bib0096","first-page":"S145","article-title":"Basal luteinizing hormone\/follicle stimulating hormone ratio in diagnosis of central precocious puberty","volume":"86","author":"Supornsilchai","year":"2003","journal-title":"J Med Assoc Thailand"},{"issue":"6","key":"10.1053\/j.semdp.2019.03.002_bib0097","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1210\/jc.2013-1024","article-title":"Treatment and outcomes of precocious puberty: an update","volume":"98","author":"Fuqua","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1053\/j.semdp.2019.03.002_bib0098","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S2213-8587(15)00380-0","article-title":"Causes, diagnosis, and treatment of central precocious puberty","volume":"4","author":"Latronico","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1053\/j.semdp.2019.03.002_bib0099","first-page":"30","article-title":"Use of leuprolide acetate response patterns in the early diagnosis of pubertal disorders: comparison with the gonadotropin-releasing hormone test","volume":"78","author":"Ib\u00e1\u00f1ez","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1053\/j.semdp.2019.03.002_bib0100","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1515\/JPEM.2008.21.12.1113","article-title":"The diagnostic value of a brief GnRH analogue stimulation test in girls with central precocious puberty: a single 30-minute post-stimulation LH sample is adequate","volume":"21","author":"Houk","year":"2008","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"4","key":"10.1053\/j.semdp.2019.03.002_bib0101","doi-asserted-by":"crossref","first-page":"e752","DOI":"10.1542\/peds.2008-1783","article-title":"Consensus statement on the use of gonadotropin-releasing hormone analogs in children","volume":"123","author":"Carel","year":"2009","journal-title":"Pediatrics"},{"issue":"7","key":"10.1053\/j.semdp.2019.03.002_bib0102","first-page":"411","article-title":"Acromegaly","volume":"110","author":"Dineen","year":"2017","journal-title":"QJM"},{"issue":"8","key":"10.1053\/j.semdp.2019.03.002_bib0103","first-page":"480","article-title":"Acromegaly","volume":"45","author":"Hossain","year":"2017","journal-title":"Med (United Kingdom)"},{"issue":"3","key":"10.1053\/j.semdp.2019.03.002_bib0104","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1210\/edrv-4-3-271","article-title":"Pathophysiology of acromegaly","volume":"4","author":"Melmed","year":"1983","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1053\/j.semdp.2019.03.002_bib0105","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s11102-006-0267-0","article-title":"Neuroendocrine tumors secreting growth hormone-releasing hormone: pathophysiological and clinical aspects","volume":"9","author":"Gola","year":"2006","journal-title":"Pituitary"},{"issue":"25","key":"10.1053\/j.semdp.2019.03.002_bib0106","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1056\/NEJM200006223422504","article-title":"Acromegaly caused by secretion of growth hormone by a Non-Hodgkins Lymphoma","volume":"342","author":"Beuschlein","year":"2000","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.semdp.2019.03.002_bib0107","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s12022-007-0006-8","article-title":"Acromegaly secondary to growth hormone-releasing hormone secreted by an incidentally discovered pheochromocytoma","volume":"18","author":"Vieira Neto","year":"2007","journal-title":"Endocr Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2019.03.002_bib0108","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2265.2009.03626.x","article-title":"Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed","volume":"72","author":"Reid","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1053\/j.semdp.2019.03.002_bib0109","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0889-8529(18)30204-4","article-title":"Clinical manifestations of acromegaly","volume":"21","author":"Motlich","year":"1992","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"7","key":"10.1053\/j.semdp.2019.03.002_bib0110","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1210\/jc.2009-2670","article-title":"A consensus on criteria for cure of acromegaly","volume":"95","author":"Giustina","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1053\/j.semdp.2019.03.002_bib0111","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly: an endocrine society clinical practice guideline","volume":"99","author":"Katznelson","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1053\/j.semdp.2019.03.002_bib0112","first-page":"3808","article-title":"Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly","volume":"83","author":"Freda","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1053\/j.semdp.2019.03.002_bib0113","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1210\/jc.2008-2421","article-title":"Guidelines for acromegaly management: an update","volume":"94","author":"Melmed","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1053\/j.semdp.2019.03.002_bib0114","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00330-004-2531-x","article-title":"Magnetic resonance imaging of pituitary adenomas","volume":"15","author":"Bonneville","year":"2005","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1053\/j.semdp.2019.03.002_bib0115","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2265.2009.03667.x","article-title":"Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)","volume":"72","author":"Fernandez","year":"2010","journal-title":"Clin Endocrinol"},{"issue":"4","key":"10.1053\/j.semdp.2019.03.002_bib0116","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1530\/eje.0.1510439","article-title":"Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry","volume":"151","author":"Mestr\u00f3n","year":"2004","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1053\/j.semdp.2019.03.002_bib0117","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1210\/er.2002-0022","article-title":"Systemic complications of acromegaly: epidemiology, pathogenesis, and management","volume":"25","author":"Colao","year":"2004","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1053\/j.semdp.2019.03.002_bib0118","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1210\/er.2009-0033","article-title":"Mortality in patients with pituitary disease","volume":"31","author":"Sherlock","year":"2010","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1053\/j.semdp.2019.03.002_bib0119","first-page":"111","article-title":"Risk of neoplasms in acromegaly","volume":"16","author":"Rucha\u0142a","year":"2012","journal-title":"Contemp Oncol (Pozn)"},{"issue":"3-4","key":"10.1053\/j.semdp.2019.03.002_bib0120","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000095531","article-title":"Cancers associated with acromegaly","volume":"83","author":"Jenkins","year":"2006","journal-title":"Neuroendocrinology"},{"issue":"3","key":"10.1053\/j.semdp.2019.03.002_bib0121","doi-asserted-by":"crossref","first-page":"559","DOI":"10.26444\/aaem\/85652","article-title":"Prevalence of neoplasms in patients with acromegaly \u2013 the need for a national registry","volume":"25","author":"Matyjaszek-Matuszek","year":"2018","journal-title":"Ann Agric Environ Med"},{"issue":"3","key":"10.1053\/j.semdp.2019.03.002_bib0122","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1210\/jc.2012-3072","article-title":"A comprehensive study of clinical, biochemical, radiological, vascular, cardiac, and sleep parameters in an unselected cohort of patients with acromegaly undergoing presurgical somatostatin receptor ligand therapy","volume":"98","author":"Annamalai","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1053\/j.semdp.2019.03.002_bib0123","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ecl.2005.01.013","article-title":"Exogenous Cushing's syndrome and glucocorticoid withdrawal","volume":"34","author":"Hopkins","year":"2005","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2","key":"10.1053\/j.semdp.2019.03.002_bib0124","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11154-010-9143-3","article-title":"The diagnosis of Cushing's syndrome","volume":"11","author":"Carroll","year":"2010","journal-title":"Rev Endocr Metab Disord"},{"issue":"9996","key":"10.1053\/j.semdp.2019.03.002_bib0125","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing's syndrome","volume":"386","author":"Lacroix","year":"2015","journal-title":"Lancet"},{"issue":"9522","key":"10.1053\/j.semdp.2019.03.002_bib0126","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","article-title":"Cushing's syndrome","volume":"367","author":"Newell-Price","year":"2006","journal-title":"Lancet"},{"issue":"4","key":"10.1053\/j.semdp.2019.03.002_bib0127","first-page":"426","article-title":"Ectopic adrenocorticotropic hormone syndrome: a diagnostic challenge and review of the literature","volume":"23","author":"Ma","year":"2010","journal-title":"Proc (Bayl Univ Med Cent)"},{"issue":"3","key":"10.1053\/j.semdp.2019.03.002_bib0128","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF03401514","article-title":"Ectopic Cushing's syndrome due to CRH secreting liver metastasis in a patient with medullary thyroid carcinoma","volume":"7","author":"Chrisoulidou","year":"2008","journal-title":"Hormones"},{"issue":"Suppl 1","key":"10.1053\/j.semdp.2019.03.002_bib0129","doi-asserted-by":"crossref","first-page":"S222","DOI":"10.1016\/j.ijsu.2014.05.035","article-title":"ACTH-secreting neuroendocrine pancreatic tumor: a case report","volume":"12","author":"Surace","year":"2014","journal-title":"Int J Surg"},{"issue":"5","key":"10.1053\/j.semdp.2019.03.002_bib0130","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1530\/eje.1.02278","article-title":"Ectopic ACTH syndrome: our experience with 25 cases","volume":"155","author":"Salgado","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1053\/j.semdp.2019.03.002_bib0131","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000094323","article-title":"Ectopic ACTH syndrome","volume":"35","author":"Isidori","year":"2006","journal-title":"Front Horm Res"},{"issue":"2","key":"10.1053\/j.semdp.2019.03.002_bib0132","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11154-010-9139-z","article-title":"The ectopic ACTH syndrome","volume":"11","author":"Alexandraki","year":"2010","journal-title":"Rev Endocr Metab Disord"},{"issue":"4","key":"10.1053\/j.semdp.2019.03.002_bib0133","first-page":"696","article-title":"Ectopic cushing's syndrome from ACTH-producing pheochromocytoma","volume":"35","author":"Gerber","year":"2013","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1053\/j.semdp.2019.03.002_bib0134","first-page":"12","article-title":"Cushing's disease: a multidisciplinary overview of the clinical features, diagnosis, and treatment","volume":"9","author":"Buliman","year":"2016","journal-title":"J Med Life"},{"issue":"6","key":"10.1053\/j.semdp.2019.03.002_bib0135","first-page":"1178","article-title":"Primary pigmented nodular adrenocortical disease: diagnosis and management","volume":"100","author":"Grant","year":"1986","journal-title":"Surgery"},{"issue":"8","key":"10.1053\/j.semdp.2019.03.002_bib0136","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1590\/S0004-27302007000800009","article-title":"Primary pigmented nodular adrenocortical disease and Cushing's syndrome","volume":"51","author":"Horvath","year":"2007","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"7","key":"10.1053\/j.semdp.2019.03.002_bib0137","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1210\/jc.2003-032247","article-title":"Cyclical cushing syndrome presenting in infancy: an early form of primary pigmented nodular adrenocortical disease, or a new entity","volume":"89","author":"Gunther","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1053\/j.semdp.2019.03.002_bib0138","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1210\/jc.2009-2321","article-title":"Cushing syndrome in the McCune-Albright syndrome","volume":"95","author":"Brown","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"1-2","key":"10.1053\/j.semdp.2019.03.002_bib0139","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.mce.2013.08.022","article-title":"Carney complex and McCune Albright syndrome: an overview of clinical manifestations and human molecular genetics","volume":"386","author":"Salpea","year":"2014","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"10.1053\/j.semdp.2019.03.002_bib0140","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/jclinpath-2014-202612","article-title":"Clinicopathological correlates of adrenal Cushing's syndrome","volume":"68","author":"Duan","year":"2015","journal-title":"J Clin Pathol"},{"key":"10.1053\/j.semdp.2019.03.002_bib0141","first-page":"281","article-title":"Cushing's syndrome: epidemiology and developments in disease management","volume":"7","author":"Sharma","year":"2015","journal-title":"Clin Epidemiol"},{"issue":"8","key":"10.1053\/j.semdp.2019.03.002_bib0142","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2015-1818","article-title":"Treatment of cushing's syndrome: an endocrine society clinical practice guideline","volume":"100","author":"Nieman","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1053\/j.semdp.2019.03.002_bib0143","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's syndrome: an endocrine society clinical practice guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1053\/j.semdp.2019.03.002_bib0144","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1210\/jc.2007-2734","article-title":"Treatment of adrenocorticotropin-dependent cushing's syndrome: a consensus statement","volume":"93","author":"Biller","year":"2008","journal-title":"J Clinic Endocrinol Metab"},{"issue":"6","key":"10.1053\/j.semdp.2019.03.002_bib0145","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1359\/jbmr.2002.17.6.1102","article-title":"Tumors associated with oncogenic osteomalacia express genes important in bone and mineral metabolism","volume":"17","author":"De Beur","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1053\/j.semdp.2019.03.002_bib0146","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1210\/jc.2012-3473","article-title":"Oncogenic osteomalacia due to FGF23-expressing colon adenocarcinoma","volume":"98","author":"Leaf","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1053\/j.semdp.2019.03.002_bib0147","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/jcp.30.4.328","article-title":"Hypophosphataemic osteomalacia associated with a malignant tumour of the tibia: report of a case","volume":"30","author":"Wyman","year":"1977","journal-title":"J Clin Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2019.03.002_bib0148","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2106\/00004623-198971020-00017","article-title":"Osteomalacia secondary to osteosarcoma. A case report","volume":"71","author":"Cheng","year":"1989","journal-title":"J Bone Jt Surg"},{"issue":"1","key":"10.1053\/j.semdp.2019.03.002_bib0149","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2169\/internalmedicine1962.21.35","article-title":"Vitamin D resistant hypophosphatemic osteomalacia associated with osteosarcoma of the mandible: report of a case","volume":"21","author":"Nomura","year":"1982","journal-title":"Jpn J Med"},{"issue":"2","key":"10.1053\/j.semdp.2019.03.002_bib0150","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/13577149977712","article-title":"Oncogenic osteomalacia as a harbinger of recurrent osteosarcoma","volume":"3","author":"Lamont","year":"1999","journal-title":"Sarcoma"},{"issue":"1","key":"10.1053\/j.semdp.2019.03.002_bib0151","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s002560050470","article-title":"Intracortical osteoblastic osteosarcoma with oncogenic rickets","volume":"28","author":"Hasegawa","year":"1999","journal-title":"Skeletal Radiol"},{"issue":"2","key":"10.1053\/j.semdp.2019.03.002_bib0152","first-page":"104","article-title":"Tumour-induced osteomalacia secondary to a sarcoma","volume":"12","author":"Rodriguez-Velver","year":"2016","journal-title":"Eur Endocrinol"},{"issue":"1","key":"10.1053\/j.semdp.2019.03.002_bib0153","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bonr.2017.09.002","article-title":"Tumor-induced osteomalacia","volume":"7","author":"Florenzano","year":"2017","journal-title":"Bone Reports"},{"issue":"10","key":"10.1053\/j.semdp.2019.03.002_bib0154","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1210\/jc.2010-0543","article-title":"Tumor-induced hypophosphatemic rickets in an adolescent boy \u2013 clinical presentation, diagnosis, and histological findings in growth plate and muscle tissue","volume":"95","author":"Haeusler","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1053\/j.semdp.2019.03.002_bib0155","first-page":"170","article-title":"Tumor-induced osteomalacia","volume":"13","author":"Minisola","year":"2017","journal-title":"Nat Rev Dis Prim"},{"issue":"3","key":"10.1053\/j.semdp.2019.03.002_bib0156","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/ERC-11-0006","article-title":"Tumor-induced osteomalacia","volume":"18","author":"Chong","year":"2011","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"10.1053\/j.semdp.2019.03.002_bib0157","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s11926-015-0512-5","article-title":"Tumor-induced osteomalacia: an up-to-date review","volume":"17","author":"Hautmann","year":"2015","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"10.1053\/j.semdp.2019.03.002_bib0158","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.anl.2008.01.003","article-title":"Malignant phosphaturic mesenchymal tumor, mixed connective tissue variant of the tongue","volume":"36","author":"Uramoto","year":"2009","journal-title":"Auris Nasus Larynx"},{"issue":"11","key":"10.1053\/j.semdp.2019.03.002_bib0159","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1016\/j.humpath.2013.04.027","article-title":"Phosphaturic mesenchymal tumor, nonphosphaturic variant, causing fatal pulmonary metastasis","volume":"44","author":"Uchihashi","year":"2013","journal-title":"Hum Pathol"},{"issue":"4","key":"10.1053\/j.semdp.2019.03.002_bib0160","doi-asserted-by":"crossref","first-page":"R147","DOI":"10.1530\/EJE-13-1012","article-title":"Management of endocrine disease: a clinical update on tumor-induced hypoglycemia","volume":"170","author":"Iglesias","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1053\/j.semdp.2019.03.002_bib0161","first-page":"258","article-title":"Update on pancreatic neuroendocrine tumors","volume":"3","author":"McKenna","year":"2014","journal-title":"Gland Surg"},{"issue":"6","key":"10.1053\/j.semdp.2019.03.002_bib0162","doi-asserted-by":"crossref","DOI":"10.5946\/ce.2017.131","article-title":"Diagnosis of Pancreatic Neuroendocrine Tumors","volume":"50","author":"Lee","year":"2017","journal-title":"Clin Endosc"},{"key":"10.1053\/j.semdp.2019.03.002_bib0163","first-page":"150","article-title":"WHO classification of the tumours of endocrine organs","author":"Kl\u00f6ppel","year":"2017"},{"issue":"2","key":"10.1053\/j.semdp.2019.03.002_bib0164","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2217\/fon.09.165","article-title":"Insulinoma: pathophysiology, localization and management","volume":"6","author":"Shin","year":"2010","journal-title":"Future Oncol"},{"issue":"4","key":"10.1053\/j.semdp.2019.03.002_bib0165","doi-asserted-by":"crossref","first-page":"R147","DOI":"10.1530\/EJE-13-1012","article-title":"A clinical update on tumor-induced hypoglycemia","volume":"170","author":"Iglesias","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1053\/j.semdp.2019.03.002_bib0166","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/0002-9343(68)90065-X","article-title":"Insulin-secreting bronchial carcinoid tumor with widespread metastases","volume":"44","author":"Shames","year":"1968","journal-title":"Am J Med"},{"issue":"1","key":"10.1053\/j.semdp.2019.03.002_bib0167","first-page":"801","article-title":"Immunoassayable insulin in carcinoma of the cervix associated with hypoglycemia","volume":"31","author":"Klang","year":"1973","journal-title":"Cancer"},{"issue":"9","key":"10.1053\/j.semdp.2019.03.002_bib0168","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/1097-0142(19820501)49:9<1920::AID-CNCR2820490927>3.0.CO;2-M","article-title":"Tumor-induced hypoglycemia: a result of ectopic insulin production","volume":"49","author":"Shetty","year":"1982","journal-title":"Cancer"},{"issue":"10","key":"10.1053\/j.semdp.2019.03.002_bib0169","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.2169\/internalmedicine.31.1239","article-title":"Paraganglioma associated with hypoglycemia","volume":"31","author":"Fujino","year":"1992","journal-title":"Intern Med"},{"issue":"10","key":"10.1053\/j.semdp.2019.03.002_bib0170","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJM199909023411004","article-title":"Hypoglycemia due to an insulin-secreting small-cell carcinoma of the cervix","volume":"341","author":"Seckl","year":"1999","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1053\/j.semdp.2019.03.002_bib0171","first-page":"292","article-title":"Hypoglycemia due to ectopic release of insulin from a paraganglioma","volume":"67","author":"Uysal","year":"2007","journal-title":"Horm Res"},{"issue":"3","key":"10.1053\/j.semdp.2019.03.002_bib0172","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/archinte.1975.00330060109016","article-title":"Hyperinsulinemic hypoglycemia associated with a neurofibrosarcoma","volume":"135","author":"Lyall","year":"1975","journal-title":"Arch Intern Med"},{"issue":"12","key":"10.1053\/j.semdp.2019.03.002_bib0173","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1177\/000313480607201216","article-title":"Hypoglycemia in the setting of advanced gastrointestinal stromal tumor","volume":"72","author":"Guiteau","year":"2006","journal-title":"Am Surg"},{"issue":"1","key":"10.1053\/j.semdp.2019.03.002_bib0174","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2407-7-13","article-title":"Severe paraneoplastic hypoglycemia in a patient with a gastrointestinal stromal tumor with an exon 9 mutation: a case report","volume":"7","author":"Escobar","year":"2007","journal-title":"BMC Cancer"},{"issue":"17","key":"10.1053\/j.semdp.2019.03.002_bib0175","doi-asserted-by":"crossref","first-page":"6778","DOI":"10.1073\/pnas.86.17.6778","article-title":"Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumors","volume":"86","author":"Daughaday","year":"1989","journal-title":"Proc Natl Acad Sci"},{"issue":"18","key":"10.1053\/j.semdp.2019.03.002_bib0176","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1056\/NEJM198112103052405","article-title":"Hypoglycemia associated with non-islet-cell tumor and insulin-like growth factors","volume":"305","author":"Gorden","year":"1981","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1053\/j.semdp.2019.03.002_bib0177","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1172\/JCI114619","article-title":"Tumor hypoglycemia: relationship to high molecular weight insulin-like growth factor-II","volume":"85","author":"Shapiro","year":"1990","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1053\/j.semdp.2019.03.002_bib0178","first-page":"15","article-title":"When a nephrectomy cures hypoglycaemia","volume":"10","author":"Oloughlin","year":"2009","journal-title":"BMJ Case Rep"},{"issue":"2","key":"10.1053\/j.semdp.2019.03.002_bib0179","first-page":"108","article-title":"Cushing's syndrome and big igf-ii associated hypoglycaemia in a patient with adrenocortical carcinoma","volume":"11","author":"Ishikura","year":"2010","journal-title":"BMJ Case Rep"},{"issue":"8","key":"10.1053\/j.semdp.2019.03.002_bib0180","first-page":"40","article-title":"Symptomatic hypoglycemia related to inappropriately high IGF-II serum levels in a patient with desmoplastic small round cell tumor","volume":"6","author":"Barra","year":"2010","journal-title":"Case Rep Med"},{"issue":"11","key":"10.1053\/j.semdp.2019.03.002_bib0181","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/qjmed\/hcq219","article-title":"Hypoglycaemia, phaeochromocytoma and features of acromegaly: a unifying diagnosis?","volume":"104","author":"Macfarlane","year":"2011","journal-title":"QJM"},{"issue":"4","key":"10.1053\/j.semdp.2019.03.002_bib0182","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.4158\/EP10381.CR","article-title":"Non-islet cell tumor hypoglycemia associated with uterine leiomyomata","volume":"17","author":"Ndzengue","year":"2011","journal-title":"Endocr Pract"},{"issue":"6","key":"10.1053\/j.semdp.2019.03.002_bib0183","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00534-007-1210-0","article-title":"Malignant transformation of a solitary fibrous tumor of the liver and intractable hypoglycemia","volume":"14","author":"Chan","year":"2007","journal-title":"J Hepatobiliary Pancreat Surg"},{"issue":"14","key":"10.1053\/j.semdp.2019.03.002_bib0184","first-page":"49","article-title":"Hypoglycemia mediated by paraneoplastic production of insulin like growth factor-II (IGF-II) by renal malignant solitary fibrous tumor","volume":"17","author":"Khowaha","year":"2013","journal-title":"Endocr Rev"},{"issue":"4","key":"10.1053\/j.semdp.2019.03.002_bib0185","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1677\/ERC-07-0161","article-title":"Non-islet cell tumour-induced hypoglycaemia: a review of the literature including two new cases","volume":"14","author":"De Groot","year":"2007","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"10.1053\/j.semdp.2019.03.002_bib0186","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ghir.2006.05.003","article-title":"Clinical features of insulin-like growth factor-II producing non-islet-cell tumor hypoglycemia","volume":"16","author":"Fukuda","year":"2006","journal-title":"Growth Horm IGF Res"},{"issue":"1","key":"10.1053\/j.semdp.2019.03.002_bib0187","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1677\/erc.0.0050111","article-title":"Tumours producing hypoglycaemia","volume":"5","author":"Marks","year":"1998","journal-title":"Endocr Relat Cancer"},{"issue":"17","key":"10.1053\/j.semdp.2019.03.002_bib0188","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1056\/NEJM199504273321707","article-title":"Hypoglycemic disorders","volume":"332","author":"Service","year":"1995","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1053\/j.semdp.2019.03.002_bib0189","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1210\/jc.2009-0153","article-title":"Hypoglycemia from IGF2 overexpression associated with activation of fetal promoters and loss of imprinting in a metastatic hemangiopericytoma","volume":"94","author":"Lawson","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1053\/j.semdp.2019.03.002_bib0190","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1210\/jc.2006-2573","article-title":"Clinical case seminar: hypoglycemia due to paraneoplastic secretion of insulin-like growth factor-I in a patient with metastasizing large-cell carcinoma of the lung","volume":"92","author":"Nauck","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1053\/j.semdp.2019.03.002_bib0191","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1210\/jc.2012-2091","article-title":"Severely fluctuating blood glucose levels associated with a somatostatin-producing ovarian neuroendocrine tumor","volume":"97","author":"Sugiyama","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1053\/j.semdp.2019.03.002_bib0192","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/MD.0b013e3181a5b42e","article-title":"Autoimmune forms of hypoglycemia","volume":"88","author":"Lupsa","year":"2009","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1053\/j.semdp.2019.03.002_bib0193","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s11606-013-2588-9","article-title":"Recurrent hypoglycemia from insulin autoimmune syndrome","volume":"29","author":"Wong","year":"2014","journal-title":"J Gen Intern Med"},{"issue":"6","key":"10.1053\/j.semdp.2019.03.002_bib0194","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1365-2265.1980.tb01382.x","article-title":"Pancreatic somatostatinoma presenting with hypoglycaemia","volume":"12","author":"Wright","year":"1980","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1053\/j.semdp.2019.03.002_bib0195","first-page":"221","article-title":"Pancreatic somatostatinoma characterized by extreme hypoglycemia","volume":"18","author":"Cao","year":"2009","journal-title":"Chin Med J (Engl)"},{"issue":"6","key":"10.1053\/j.semdp.2019.03.002_bib0196","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1210\/jc.2007-0075","article-title":"Hypoglycemia due to an insulin binding antibody in a patient with an IgA-kappa myeloma","volume":"92","author":"Halsall","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1053\/j.semdp.2019.03.002_bib0197","first-page":"164","article-title":"Autoimmune dysglycemia: the pendulum swings","volume":"34","author":"Torregosa","year":"2012","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1053\/j.semdp.2019.03.002_bib0198","first-page":"221","article-title":"Pancreatic somatostatinoma manifested as severe hypoglycemia","volume":"18","author":"He","year":"2009","journal-title":"J Gastrointest Liver Dis"},{"issue":"9353","key":"10.1053\/j.semdp.2019.03.002_bib0199","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0140-6736(03)12256-8","article-title":"A tumour that secretes glucagon-like peptide-1 and somatostatin in a patient with reactive hypoglycaemia and diabetes","volume":"361","author":"Todd","year":"2003","journal-title":"Lancet"},{"issue":"2","key":"10.1053\/j.semdp.2019.03.002_bib0200","first-page":"101","article-title":"Molecular signature of salivary gland tumors: potential use as diagnostic and prognostic marker","volume":"45","author":"Fonseca","year":"2016","journal-title":"J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol"},{"issue":"12 Suppl","key":"10.1053\/j.semdp.2019.03.002_bib0201","first-page":"ECR50","article-title":"Recurrent hypoglycemia and hypothermia in a patient with Hodgkin's disease","volume":"91","author":"Kulkarni","year":"2006","journal-title":"Haematologica"},{"issue":"1","key":"10.1053\/j.semdp.2019.03.002_bib0202","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAP.0000000000000201","article-title":"Neoplasms of the neuroendocrine pancreas: an update in the classification, definition, and molecular genetic advances","volume":"26","author":"Guilmette","year":"2018","journal-title":"Adv Anat Pathol"},{"issue":"5","key":"10.1053\/j.semdp.2019.03.002_bib0203","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1530\/eje.0.1510531","article-title":"The glucagonoma syndrome and necrolytic migratory erythema: a clinical review","volume":"151","author":"van Beek","year":"2004","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1053\/j.semdp.2019.03.002_bib0204","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/ijd.13947","article-title":"A review of cutaneous manifestations within glucagonoma syndrome: necrolytic migratory erythema","volume":"57","author":"Tolliver","year":"2018","journal-title":"Int J Dermatol"},{"issue":"3","key":"10.1053\/j.semdp.2019.03.002_bib0205","first-page":"2749","article-title":"Glucagonoma and the glucagonoma syndrome","volume":"15","author":"Song","year":"2018","journal-title":"Oncol Lett"},{"key":"10.1053\/j.semdp.2019.03.002_bib0206","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00005792-199603000-00002","article-title":"The glucagonoma syndrome. Clinical and pathologic features in 21 patients","volume":"75","author":"Wermers","year":"1996","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"10.1053\/j.semdp.2019.03.002_bib0207","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/00000441-200105000-00003","article-title":"The glucagonoma syndrome: a review of its features and discussion of new perspectives","volume":"321","author":"Chastain","year":"2001","journal-title":"Am J Med Sci"},{"issue":"5","key":"10.1053\/j.semdp.2019.03.002_bib0208","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2265.2011.03967.x","article-title":"Glucagonoma and the glucagonoma syndrome \u2013 cumulative experience with an elusive endocrine tumour","volume":"74","author":"Eldor","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"10.1053\/j.semdp.2019.03.002_bib0209","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s11606-013-2490-5","article-title":"Putting the pieces together: necrolytic migratory erythema and the glucagonoma syndrome","volume":"28","author":"Halvorson","year":"2013","journal-title":"J Gen Intern Med"},{"issue":"2","key":"10.1053\/j.semdp.2019.03.002_bib0210","first-page":"122","article-title":"Necrolytic migratory erythema as the first manifestation of pancreatic neuroendocrine tumor","volume":"17","author":"Wu","year":"2014","journal-title":"World J Surg Oncol"},{"issue":"1","key":"10.1053\/j.semdp.2019.03.002_bib0211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/709152","article-title":"Zinc therapy in dermatology: a review","volume":"2014","author":"Gupta","year":"2014","journal-title":"Dermatol Res Pract"},{"issue":"3","key":"10.1053\/j.semdp.2019.03.002_bib0212","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s12032-007-0011-2","article-title":"Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years","volume":"24","author":"Kindmark","year":"2007","journal-title":"Med Oncol"},{"key":"10.1053\/j.semdp.2019.03.002_bib0213","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s005340050052","article-title":"Glucagonomas\/diabetico-dermatogenic syndrome (DDS): a statistical evaluation of 407 reported cases","volume":"5","author":"Soga","year":"1998","journal-title":"J Hepatobiliary Pancreat Surg"},{"issue":"2","key":"10.1053\/j.semdp.2019.03.002_bib0214","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.soc.2015.12.003","article-title":"Clinical presentation and diagnosis of pancreatic neuroendocrine tumors","volume":"25","author":"Anderson","year":"2016","journal-title":"Surg Oncol Clin N Am"},{"issue":"5","key":"10.1053\/j.semdp.2019.03.002_bib0215","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1053\/j.gastro.2008.05.047","article-title":"Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors","volume":"135","author":"Metz","year":"2008","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1053\/j.semdp.2019.03.002_bib0216","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nrgastro.2012.9","article-title":"Well-differentiated pancreatic neuroendocrine tumors: from genetics to therapy","volume":"9","author":"De Wilde","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1053\/j.semdp.2019.03.002_bib0217","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/0002-9343(58)90075-5","article-title":"Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia","volume":"25","author":"Verner J","year":"1958","journal-title":"Am J Med"},{"issue":"2","key":"10.1053\/j.semdp.2019.03.002_bib0218","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s11605-007-0177-0","article-title":"Pancreatic VIPomas: subject review and one institutional experience","volume":"12","author":"Ghaferi","year":"2008","journal-title":"J Gastrointest Surg"},{"issue":"7","key":"10.1053\/j.semdp.2019.03.002_bib0219","first-page":"22","article-title":"VIPoma syndrome: challenges in management","volume":"51","author":"Adam","year":"2010","journal-title":"Singapore Med J"},{"issue":"8","key":"10.1053\/j.semdp.2019.03.002_bib0220","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/jhbp.226","article-title":"Clinical features of pancreatic neuroendocrine tumors","volume":"22","author":"Grozinsky-Glasberg","year":"2015","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"7","key":"10.1053\/j.semdp.2019.03.002_bib0221","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/MPA.0b013e3181b2bc7c","article-title":"Diagnosis and treatment of pancreatic vasoactive intestinal peptide endocrine tumors","volume":"38","author":"Song","year":"2009","journal-title":"Pancreas"},{"issue":"12","key":"10.1053\/j.semdp.2019.03.002_bib0222","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1185\/03007990903328959","article-title":"From somatostatin to octreotide LAR: evolution of a somatostatin analogue","volume":"25","author":"Anthony","year":"2009","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"10.1053\/j.semdp.2019.03.002_bib0223","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1177\/1758834016656495","article-title":"Emergency therapy for liver metastases from advanced VIPoma: surgery or transarterial chemoembolization","volume":"8","author":"Dr\u00e9anic","year":"2016","journal-title":"Ther Adv Med Oncol"},{"issue":"22","key":"10.1053\/j.semdp.2019.03.002_bib0224","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1200\/JCO.2011.35.1817","article-title":"Prognostic validity of a Novel American Joint Committee on Cancer staging classification for pancreatic neuroendocrine tumors","volume":"29","author":"Strosberg","year":"2011","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1053\/j.semdp.2019.03.002_bib0225","first-page":"389","article-title":"Vipoma\/diarrheogenic syndrome: a statistical evaluation of 241 reported cases","volume":"17","author":"Soga","year":"1998","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257019300206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257019300206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:21:25Z","timestamp":1760037685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257019300206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":225,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0740257019300206"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2019.03.002","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paraneoplastic syndromes and other systemic disorders associated with neuroendocrine neoplasms","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semdp.2019.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}